References
- Teitelbaum, S. L. and Ross, F. P. (2003) Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649. https://doi.org/10.1038/nrg1122
- Harada, S. and Rodan, G. A. (2003) Control of osteoblast function and regulation of bone mass. Nature 423, 349-355. https://doi.org/10.1038/nature01660
- Raisz, L. G. (2005) Clinical practice. Screening for osteoporosis. N. Engl. J. Med. 353, 164-171. https://doi.org/10.1056/NEJMcp042092
- Riggs, B. L., Khosla, S. and Melton, L. J. 3rd. (1998) A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J. Bone Miner. Res. 13, 763-773. https://doi.org/10.1359/jbmr.1998.13.5.763
- Ricci, T. A., Heymsfield, S. B., Pierson, R. N. Jr., Stahl, T., Chowdhury, H. A. and Shapses, S. A. (2001) Moderate energy restriction increases bone resorption in obese postmenopausal women. Am. J. Clin. Nutr. 73, 347-352. https://doi.org/10.1093/ajcn/73.2.347
- Grinspoon, S., Thomas, E., Pitts, S., Gross, E., Mickley, D., Miller, K., Herzog, D. and Klibanski, A. (2000) Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann. Intern. Med. 133, 790-794. https://doi.org/10.7326/0003-4819-133-10-200011210-00011
- Karsenty, G. (2006) Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab. 4, 341-348. https://doi.org/10.1016/j.cmet.2006.10.008
- Felson, D. T., Zhang, Y., Hannan, M. T. and Anderson, J. J. (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J. Bone Miner. Res. 8, 567-573. https://doi.org/10.1002/jbmr.5650080507
- Tremollieres, F. A., Pouilles, J. M. and Ribot, C. (1993) Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 earlypostmenopausal women. J. Clin. Endocrinol. Metab. 77, 683-686. https://doi.org/10.1210/jc.77.3.683
- Ahima, R. S. (2004) Body fat, leptin, and hypothalamic amenorrhea. N. Engl. J. Med. 351, 959-962. https://doi.org/10.1056/NEJMp048214
- Spiegelman, B. M., and Flier, J. S. (2001) Obesity and the regulation of energy balance. Cell 104, 531-543. https://doi.org/10.1016/S0092-8674(01)00240-9
- Auwerx, J. and Staels, B. (1998) Leptin. Lancet 351, 737-742. https://doi.org/10.1016/S0140-6736(97)06348-4
- Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M. and Karsenty, G. (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197-207. https://doi.org/10.1016/S0092-8674(00)81558-5
- Ahima, R. S., Saper, C. B., Flier, J. S. and Elmquist, J. K. (2000) Leptin regulation of neuroendocrine systems. Front. Neuroendocrinol. 21, 263-307. https://doi.org/10.1006/frne.2000.0197
- Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., Clement, K., Vaisse, C. and Karsenty, G. (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514-520. https://doi.org/10.1038/nature03398
- Martin, A., de Vittoris, R., David, V., Moraes, R., Begeot, M., Lafage-Proust, M. H., Alexandre, C., Vico, L. and Thomas, T. (2005) Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats. Endocrinology 146, 3652-3659. https://doi.org/10.1210/en.2004-1509
- Cornish, J., Callon, K. E., Bava, U., Lin, C., Naot, D., Hill, B. L., Grey, A. B., Broom, N., Myers, D. E., Nicholson, G. C. and Reid, I. R. (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 175, 405-415. https://doi.org/10.1677/joe.0.1750405
- Elefteriou, F., Takeda, S., Ebihara, K., Magre, J., Patano, N., Kim, C. A., Ogawa, Y., Liu, X., Ware, S. M., Craigen, W. J., Robert, J. J., Vinson, C., Nakao, K., Capeau, J. and Karsenty, G. (2004) Serum leptin level is a regulator of bone mass. Proc. Natl. Acad. Sci. U.S.A. 101, 3258-3263. https://doi.org/10.1073/pnas.0308744101
- Lian, J., Stewart, C., Puchacz, E., Mackowiak, S., Shalhoub, V., Collart, D., Zambetti, G. and Stein, G. (1989) Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc. Natl. Acad. Sci. U.S.A. 86, 1143-1147. https://doi.org/10.1073/pnas.86.4.1143
- Hauschka, P. V., Lian, J. B., Cole, D. E. and Gundberg, C. M. (1989) Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol. Rev. 69, 990-1047. https://doi.org/10.1152/physrev.1989.69.3.990
- Price, P. A. (1989) Gla-containing proteins of bone. Connect. Tissue. Res. 21, 51-57. https://doi.org/10.3109/03008208909049995
- Hetzel, P. G., Glanzmann, R., Hasler, P. W., Ladewick, A. and Buhrer, C. (2006) Coumarin embryopathy in an extremely low birth weight infant associated with neonatal hepatitis and ocular malformations. Eur. J. Pediatr. 165, 358-360. https://doi.org/10.1007/s00431-005-0064-1
- Obrant, K. J., Kakonen, S. M., Astermark, J., Lilja, H., Lovgren, T., Akesson, K. and Pettersson, K. (1999) The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects. J. Bone. Miner. Res. 14, 555-560. https://doi.org/10.1359/jbmr.1999.14.4.555
- Sayinalp, S., Gedik, O. and Koray, Z. (1995) Increasing serum osteocalcin after glycemic control in diabetic men. Calcif. Tissue Int. 57, 422-425. https://doi.org/10.1007/BF00301944
- Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., Zhang, Z., Kim, J. K,. Mauvais-Jarvis, F., Ducy, P. and Karsenty, G. (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456-469. https://doi.org/10.1016/j.cell.2007.05.047
- Mauro, L. J., Olmsted, E. A., Skrobacz, B. M., Mourey, R. J., Davis, A. R. and Dixon, J. E. (1994) Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J. Biol. Chem. 269, 30659-30667.
- Dacquin, R., Mee, P. J., Kawaguchi, J., Olmsted-Davis, E. A., Gallagher, J. A., Nichols, J., Lee, K., Karsenty, G. and Smith, A. (2004) Knock-in of nuclear localised betagalactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar. Dev. Dyn. 229, 826-834. https://doi.org/10.1002/dvdy.20003
- Ferron, M., Wei, J., Yoshizawa, T., Ducy, P. and Karsenty, G. (2010) An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochem. Biophys. Res. Commun. [Epub ahead of print].
- Ferron, M., Hinoi, E., Karsenty, G. and Ducy, P. (2008) Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. U.S.A. 105, 5266-5270. https://doi.org/10.1073/pnas.0711119105
- Yoshizawa, T., Hinoi, E., Jung, D. Y., Kajimura, D., Ferron, M., Seo, J., Graff, J. M., Kim, J. K. and Karsenty, G. (2009) The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J. Clin. Invest. 119, 2807-2817. https://doi.org/10.1172/JCI39366
- Rached, M. T., Kode, A., Silva, B. C., Jung, D. Y., Gray, S., Ong, H., Paik, J. H., DePinho, R. A., Kim, J. K., Karsenty, G. and Kousteni, S. (2010) FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J. Clin. Invest. 120, 357-368. https://doi.org/10.1172/JCI39901
- Yang, X., Matsuda, K., Bialek, P., Jacquot, S., Masuoka, H. C., Schinke, T., Li, L., Brancorsini, S., Sassone-Corsi, P., Townes, T. M., Hanauer, A. and Karsenty, G. (2004) ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117, 387-398. https://doi.org/10.1016/S0092-8674(04)00344-7
- Accili, D. and Arden, K. C. (2004) FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117, 421-426. https://doi.org/10.1016/S0092-8674(04)00452-0
- Nakae, J., Biggs, W. H. 3rd, Kitamura, T., Cavenee, W. K., Wright, C. V., Arden, K. C. and Accili, D. (2002) Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32, 245-253. https://doi.org/10.1038/ng890
- Matsumoto, M., Pocai, A., Rossetti, L., DePinho, R. A. and Accili, D. (2007) Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 6, 208-216. https://doi.org/10.1016/j.cmet.2007.08.006
- Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H. 3rd, Arden, K. C. and Accili, D. (2003) The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell. 4, 119-129. https://doi.org/10.1016/S1534-5807(02)00401-X
- Rached, M. T., Kode, A., Silva, B. C., Jung, D. Y., Gray, S., Ong, H., Paik, J. H., DePinho, R. A., Kim, J. K., Karsenty, G. and Kousteni, S. (2010) FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J. Clin. Invest. 120, 357-368. https://doi.org/10.1172/JCI39901
- Hinoi, E., Gao, N., Jung, D. Y., Yadav, V., Yoshizawa, T., Myers, M. G. Jr., Chua, S. C. Jr., Kim, J. K., Kaestner, K. H. and Karsenty, G. (2008) The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J. Cell Biol. 183, 1235-1242. https://doi.org/10.1083/jcb.200809113
- Morioka, T., Asilmaz, E., Hu, J. Dishinger, J. F., Kurpad, A. J., Elias, C. F., Li, H., Elmquist, J. K., Kennedy, R. T. and Kulkarni, R. N. (2007) Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J. Clin. Invest. 117, 2860-2868. https://doi.org/10.1172/JCI30910
- Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P. and Karsenty, G. (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305-317. https://doi.org/10.1016/S0092-8674(02)01049-8
- Hinoi, E., Gao, N., Jung, D. Y., Yadav, V., Yoshizawa, T., Kajimura, D., Myers, M. G. Jr., Chua, S. C. Jr., Wang, Q., Kim, J. K., Kaestner, K. H. and Karsenty, G. (2009) An Osteoblast-dependent mechanism contributes to the leptin regulation of insulin secretion. Ann. N. Y. Acad. Sci. 1173, E20-30. https://doi.org/10.1111/j.1749-6632.2009.05061.x
- Hwang, Y. C., Jeong, I. K., Ahn, K. J. and Chung, H. Y. (2009) The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab. Res. Rev. 25, 768-772. https://doi.org/10.1002/dmrr.1045
- Winhofer, Y., Handisurya, A., Tura, A., Bittighofer, C., Klein, K., Schneider, B., Bieglmayer, C., Wagner, O. F., Pacini, G., Luger, A. and Kautzky-Willer, A. (2010) Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care 33, 139-143. https://doi.org/10.2337/dc09-1237
- Pittas, A. G., Harris, S. S., Eliades, M., Stark, P. and Dawson-Hughes, B. (2009) Association between serum osteocalcin and markers of metabolic phenotype. J. Clin. Endocrinol. Metab. 94, 827-832. https://doi.org/10.1210/jc.2008-1422
Cited by
- Young overweight and obese women with lower circulating osteocalcin concentrations exhibit higher insulin resistance and concentrations of C-reactive protein vol.33, pp.1, 2013, https://doi.org/10.1016/j.nutres.2012.11.011
- Osteocalcin is a predictor for diabetes mellitus in postmenopausal women and correlated with oral intake of vitamin k vol.8, pp.3, 2015, https://doi.org/10.3233/MNM-150049
- Evolution of Leptin Structure and Function vol.94, pp.1, 2011, https://doi.org/10.1159/000328435
- The systemic nature of CKD vol.13, pp.6, 2017, https://doi.org/10.1038/nrneph.2017.52